Mechanotransduction is the process by which cells convert mechanical stimuli into biochemical signals, crucial for hearing in cochlear hair cells. The transmembrane channel-like proteins TMC1 and TMC2 are integral components of the mechanotransduction (MET) channel, while calcium and integrin-binding proteins CIB2 and CIB3 play supportive roles in channel assembly and function.
Mutations in TMC1 and TMC2 have been linked to various forms of hearing loss, including autosomal dominant and recessive types. For instance, the TMC1 Beethoven mutation (M412K) results in reduced calcium selectivity and impaired adaptation of the MET channel, which is essential for responding to sound stimuli. This mutation leads to a significant decrease in the channel's ability to conduct calcium ions, crucial for the hair cell's response to mechanical deflection ().
Mutations in CIB2 and CIB3 also significantly impact mechanotransduction. CIB2 acts as a calcium sensor and is essential for the proper functioning of the MET channel. Mutations in CIB2 can disrupt its interaction with TMC1, leading to impaired channel assembly and function. For example, the CIB2 mutation DD116/120AA shows a 25-fold decrease in calcium binding affinity, resulting in mislocalization of the protein and loss of MET current in hair cells ().
Both types of mutations contribute to hearing loss but through different mechanisms: TMC mutations directly impair channel function, while CIB mutations affect the structural integrity and assembly of the mechanotransduction complex.
Understanding the specific effects of these mutations is crucial for developing targeted therapies for hearing loss. Genetic insights can guide more informed approaches to treatment, emphasizing the need for research that focuses on the molecular mechanisms underlying these conditions.